ADAPTIVE PHAGE THERAPEUTICS
Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria. Its services are provided using clinical and therapeutic technology that matches phages to patient-specific bacterial infections, enabling medical researchers to develop drugs that can detect and eliminate multi-drug resistant bacteria.
ADAPTIVE PHAGE THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Bethesda, Maryland, United States
Country:
United States
Website Url:
http://www.aphage.com
Total Employee:
51+
Status:
Active
Contact:
2408992532
Total Funding:
131.68 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Amazon SSL By Default Font Awesome Mobile Non Scaleable Content IPv6 Cloudflare Hosting
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
AMR Action Fund
AMR Action Fund investment in Series B - Adaptive Phage Therapeutics
Deerfield Capital Management
Deerfield Capital Management investment in Series B - Adaptive Phage Therapeutics
Defense Health Agency
Defense Health Agency investment in Grant - Adaptive Phage Therapeutics
AMR Action Fund
AMR Action Fund investment in Series B - Adaptive Phage Therapeutics
Mayo Clinic
Mayo Clinic investment in Series B - Adaptive Phage Therapeutics
Deerfield
Deerfield investment in Series B - Adaptive Phage Therapeutics
Mayo Clinic
Mayo Clinic investment in Convertible Note - Adaptive Phage Therapeutics
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Adaptive Phage Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Venture Round - Adaptive Phage Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-23 | Adaptive Phage Therapeutics Appoints Michele Wales, Ph.D., J.D., as Chief Legal Officer |
Official Site Inspections
http://www.aphage.com Semrush global rank: 11.68 M Semrush visits lastest month: 153
- Host name: 104.21.37.233
- IP address: 104.21.37.233
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Adaptive Phage Therapeutics"
Adaptive Phage Therapeutics - Crunchbase Company …
Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.See details»
BiomX Announces Entry into Merger Agreement with Adaptive …
Mar 6, 2024 Acquisition will create phage therapy company with an advanced pipeline with two Phase 2 assets, BX004 for the treatment of chronic pulmonary infections in cystic fibrosis …See details»
Adaptive Phage Therapeutics - LinkedIn
Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing therapies addressing multi-drug resistant infections. Prior antimicrobial therapeutic approaches have been “fixed ...See details»
BiomX | Phage therapy
Nov 14, 2024 We have entered into two collaborations with Boehringer Ingelheim. Our first collaboration with Boehringer Ingelheim was announced in September 2020 (see press …See details»
Adaptive Phage Therapeutics - Datanyze
SQL International Organization for Standardization . Python Python . Other Vertical Industries Software (4 Technologies) Facebook Signal Facebook . ... [email protected]: 6: last: …See details»
Adaptive Phage Therapeutics, Inc. - Drug pipelines, Patents
Www.aphage.com. Startups | Subsidiary Company | 2016 | Maryland, United States | 50-100 | www.aphage.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Adaptive Phage Therapeutics - Overview, News & Similar
Aug 28, 2023 www.aphage.com. Revenue $21.3 Million. Industry Medical Testing & Clinical Laboratories Healthcare . Most Recent Scoops. Mar 19 2024. Left Company. Aug 28 2023. …See details»
Adaptive Phage Therapeutics - PitchBook
Jun 8, 2021 Adaptive Phage Therapeutics General Information Description. Operator of a clinical-stage company intended to treat multi-drug resistant pathogenic bacteria. The …See details»
Working at Adaptive Phage Therapeutics - Zippia
Www.aphage.com. Organization Type. Private. Social Media. Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the …See details»
Adaptive Phage Therapeutics - Craft
Adaptive Phage Therapeutics has 5 employees across 2 locations and $20.32 m in total funding,. See insights on Adaptive Phage Therapeutics including office locations, competitors, revenue, …See details»
Adaptive Phage Therapeutics - Employees, Contact info, Overview
Apr 30, 2024 View info about Adaptive Phage Therapeutics (aphage.com). Adaptive Phage Therapeutics is a company located in Gaithersburg, Maryland, United States. Find employees, …See details»
Adaptive Phage Therapeutics CEO and Key Executive Team
Adaptive Phage Therapeutics's Chief Executive Officer, Board Chairman is Greg Merril. Other executives include Carl R Merril, Chief Scientific Officer, Board Director; Subhendu Basu, …See details»
Adaptive Phage Overview on Vimeo
Jan 27, 2023 APT’s clinical development program has attracted substantial financial support from The Defense Health Agency (DHA), NIAID/NIH, The Mayo Clinic, the AMR Action Fund, …See details»
Adaptive Phage Therapeutics, Inc. | TEDCO - tedcomd.com
Feb 11, 2020 Adaptive Phage Therapeutics, a TEDCO portfolio company, update: FDA Clears First Clinical Study for a Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant …See details»
Greg Merril of Adaptive Phage Therapeutics: “The actual ... - Medium
Jun 14, 2020 According to the World Health Organization, there is a US $100 trillion potential cost in terms of lost global production between now and 2050.[1] ... visit APT’s web site at: …See details»
Top 25 Pharmaceutical Companies in Maryland - inven.ai
Website: aphage.com; Headquarters: Gaithersburg, Maryland, United States; Founded: 2016; Headcount: 11-50; Latest funding type: Grant; LinkedIn; ... Fast-Track Drugs and Biologics, …See details»
Adaptive Phage Therapeutics Extends Series B to $61 million with ...
Apr 4, 2022 The concept of the AMR Action Fund was developed by the International Federation of Pharmaceutical Manufacturers & Associations and its member biopharmaceutical …See details»
Adaptive Phage Therapeutics - Terminally Ill Patient Successfully ...
Apr 26, 2017 Adaptive Phage Therapeutics, Inc. (APT) Greg Merril, CEO, 240-899-2532 [email protected] Contacts Adaptive Phage Therapeutics, Inc. (APT) Greg Merril, CEO, …See details»
Adaptive Phage Therapeutics - Adaptive Phage Therapeutics …
GAITHERSBURG, Md., August 19, 2020 – Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat the global rise of bacterial …See details»
Evolutionary necessity and issues associated with phage andphage ...
E-mail: [email protected] Leticia V. Bentancor, Ph.D. Laboratory of Genetic Engineering and Molecular Biology, Institute of Basic and Applied Microbiology, National University of Quilmes, …See details»